US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 1.975
  • -0.155-7.28%
Trading Apr 25 15:57 ET
374.07MMarket Cap-972P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
54.14%116.33M
71.38%32.25M
78.97%33.97M
36.86%25.79M
29.16%24.33M
-3.79%75.48M
22.19%18.82M
31.72%18.98M
-53.66%18.84M
136.10%18.84M
Operating revenue
54.14%116.33M
71.38%32.25M
78.97%33.97M
36.86%25.79M
29.16%24.33M
-3.79%75.48M
22.19%18.82M
31.72%18.98M
-53.66%18.84M
136.10%18.84M
Cost of revenue
60.44%43.27M
175.29%11.45M
105.61%13.38M
-26.05%6.79M
63.54%11.65M
89.68%26.97M
-18.03%4.16M
17.06%6.51M
409.78%9.18M
299.38%7.13M
Gross profit
50.63%73.07M
41.89%20.8M
65.08%20.59M
96.59%19M
8.25%12.68M
-24.48%48.51M
41.95%14.66M
40.93%12.47M
-75.13%9.67M
89.07%11.71M
Operating expense
0.27%228.63M
10.48%63.17M
-11.04%48.13M
-9.64%56.06M
12.03%61.28M
-21.64%228.01M
-13.32%57.17M
-16.25%54.1M
-13.10%62.04M
-38.55%54.7M
Selling and administrative expenses
30.66%142.52M
88.18%45.42M
33.21%33.24M
14.69%33.96M
-1.58%29.9M
-41.03%109.08M
-37.04%24.14M
-36.45%24.95M
-36.07%29.61M
-50.25%30.38M
Research and development costs
-27.60%86.11M
-46.29%17.74M
-48.92%14.89M
-31.86%22.1M
29.04%31.38M
12.22%118.93M
19.62%33.03M
15.05%29.14M
29.35%32.43M
-13.00%24.32M
Operating profit
13.34%-155.56M
0.34%-42.37M
33.85%-27.53M
29.25%-37.06M
-13.06%-48.61M
20.83%-179.5M
23.58%-42.51M
25.33%-41.62M
-60.99%-52.38M
48.10%-42.99M
Net non-operating interest income expense
-3.81%-58.98M
-5.08%-15.06M
-5.95%-15M
-1.90%-14.54M
-2.31%-14.39M
-22.56%-56.81M
-6.69%-14.33M
-3.65%-14.15M
-28.02%-14.27M
-73.07%-14.06M
Non-operating interest expense
3.81%58.98M
5.08%15.06M
5.95%15M
1.90%14.54M
2.31%14.39M
22.56%56.81M
6.69%14.33M
3.65%14.15M
28.02%14.27M
73.07%14.06M
Other net income (expense)
99.51%5.29M
-20.30%1.08M
93.93%1.28M
422.01%1.66M
297.81%1.27M
-33.28%2.65M
-65.60%1.36M
4,969.23%659K
3,433.33%318K
2,185.71%320K
Other non- operating income (expenses)
99.51%5.29M
-20.30%1.08M
93.93%1.28M
422.01%1.66M
297.81%1.27M
-33.28%2.65M
-65.60%1.36M
4,969.23%659K
3,433.33%318K
2,185.71%320K
Income before tax
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
37.61%-56.73M
Income tax
Net income
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
37.61%-56.73M
Net income continuous Operations
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
37.61%-56.73M
Minority interest income
Net income attributable to the parent company
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
37.61%-56.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
37.61%-56.73M
Basic earnings per share
42.33%-2.03
34.21%-0.5
54.32%-0.37
56.19%-0.46
15.05%-0.79
62.19%-3.52
57.06%-0.76
69.08%-0.81
37.13%-1.05
73.43%-0.93
Diluted earnings per share
42.33%-2.03
34.21%-0.5
54.32%-0.37
56.19%-0.46
15.05%-0.79
62.19%-3.52
57.06%-0.76
69.08%-0.81
37.13%-1.05
73.43%-0.93
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 54.14%116.33M71.38%32.25M78.97%33.97M36.86%25.79M29.16%24.33M-3.79%75.48M22.19%18.82M31.72%18.98M-53.66%18.84M136.10%18.84M
Operating revenue 54.14%116.33M71.38%32.25M78.97%33.97M36.86%25.79M29.16%24.33M-3.79%75.48M22.19%18.82M31.72%18.98M-53.66%18.84M136.10%18.84M
Cost of revenue 60.44%43.27M175.29%11.45M105.61%13.38M-26.05%6.79M63.54%11.65M89.68%26.97M-18.03%4.16M17.06%6.51M409.78%9.18M299.38%7.13M
Gross profit 50.63%73.07M41.89%20.8M65.08%20.59M96.59%19M8.25%12.68M-24.48%48.51M41.95%14.66M40.93%12.47M-75.13%9.67M89.07%11.71M
Operating expense 0.27%228.63M10.48%63.17M-11.04%48.13M-9.64%56.06M12.03%61.28M-21.64%228.01M-13.32%57.17M-16.25%54.1M-13.10%62.04M-38.55%54.7M
Selling and administrative expenses 30.66%142.52M88.18%45.42M33.21%33.24M14.69%33.96M-1.58%29.9M-41.03%109.08M-37.04%24.14M-36.45%24.95M-36.07%29.61M-50.25%30.38M
Research and development costs -27.60%86.11M-46.29%17.74M-48.92%14.89M-31.86%22.1M29.04%31.38M12.22%118.93M19.62%33.03M15.05%29.14M29.35%32.43M-13.00%24.32M
Operating profit 13.34%-155.56M0.34%-42.37M33.85%-27.53M29.25%-37.06M-13.06%-48.61M20.83%-179.5M23.58%-42.51M25.33%-41.62M-60.99%-52.38M48.10%-42.99M
Net non-operating interest income expense -3.81%-58.98M-5.08%-15.06M-5.95%-15M-1.90%-14.54M-2.31%-14.39M-22.56%-56.81M-6.69%-14.33M-3.65%-14.15M-28.02%-14.27M-73.07%-14.06M
Non-operating interest expense 3.81%58.98M5.08%15.06M5.95%15M1.90%14.54M2.31%14.39M22.56%56.81M6.69%14.33M3.65%14.15M28.02%14.27M73.07%14.06M
Other net income (expense) 99.51%5.29M-20.30%1.08M93.93%1.28M422.01%1.66M297.81%1.27M-33.28%2.65M-65.60%1.36M4,969.23%659K3,433.33%318K2,185.71%320K
Other non- operating income (expenses) 99.51%5.29M-20.30%1.08M93.93%1.28M422.01%1.66M297.81%1.27M-33.28%2.65M-65.60%1.36M4,969.23%659K3,433.33%318K2,185.71%320K
Income before tax 10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M-51.88%-66.32M37.61%-56.73M
Income tax
Net income 10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M-51.88%-66.32M37.61%-56.73M
Net income continuous Operations 10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M-51.88%-66.32M37.61%-56.73M
Minority interest income
Net income attributable to the parent company 10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M-51.88%-66.32M37.61%-56.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M-51.88%-66.32M37.61%-56.73M
Basic earnings per share 42.33%-2.0334.21%-0.554.32%-0.3756.19%-0.4615.05%-0.7962.19%-3.5257.06%-0.7669.08%-0.8137.13%-1.0573.43%-0.93
Diluted earnings per share 42.33%-2.0334.21%-0.554.32%-0.3756.19%-0.4615.05%-0.7962.19%-3.5257.06%-0.7669.08%-0.8137.13%-1.0573.43%-0.93
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg